HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

This adverse event was reported 7512 times

HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EMAPALUMAB-LZSG 72 0.3038
1 ANAKINRA 725 0.0429
2 VANCOMYCIN HYDROCHLORIDE 259 0.0310
3 CANAKINUMAB 297 0.0272
4 BARICITINIB 76 0.0249
5 CILTACABTAGENE AUTOLEUCEL 133 0.0203
6 AXICABTAGENE CILOLEUCEL 143 0.0141
7 GANCICLOVIR SODIUM 150 0.0140
8 FOSCARNET SODIUM 53 0.0132
9 FLUDARABINE PHOSPHATE 447 0.0112
See all drugs enriched for association with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS